- /
- Supported exchanges
- / SA
- / D1EX34.SA
DexCom Inc. (D1EX34 SA) stock market data APIs
DexCom Inc. Financial Data Overview
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get DexCom Inc. data using free add-ons & libraries
Get DexCom Inc. Fundamental Data
DexCom Inc. Fundamental data includes:
- Net Revenue: 5 104 M
- EBITDA: 1 499 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DexCom Inc. News
New
Advancing type 1 diabetes care during pregnancy: a Canadian first
Health Canada has approved Dexcom G7 for use with myLoop, powered by CamAPS FX, making it the only automated insulin delivery system in Canada approved for use during pregnancy in women living with ty...
He went from washing lab equipment for $10 an hour to leading a $30 billion healthcare company. His advice to Gen Z: Raise your hand
The road to the corner office doesn't always start with an Ivy League degree or prestigious internship. For Jake Leach, it started working as a lab dishwasher for just $10 an hour. Back in the 1990s,...
Guardant Health (GH) Could Be 17% Undervalued As Board Appointment Tests Valuation
Guardant Health (GH) has drawn fresh attention after appointing Kevin Sayer, former Dexcom CEO and current Executive Chairman, to its board of directors. The move is raising new questions about where ...
Will Shield Award Recognition Change Guardant Health Stock Narrative
Guardant Health reported that its Shield blood test for colorectal cancer screening received the 2026 Prix Galien USA Award for Best Medical Technology, recognizing the first FDA approved blood test f...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.